CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Clinical Investigation

• Publication date

  2008-12-08

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI35535PMID 19065049PMCID PMC2613464
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Absence of CD36 protects against atherosclerosis in ApoE knock-out mice with no additional protection provided by absence of scavenger receptor A I/II.

  2008cited by this paper
• Continued inhibition of atherosclerotic lesion development in long term Western diet fed CD36o /apoEo mice .

  2007cited by this paper
• Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype

  2007cited by this paper
• Oxidative Modification of Protein Tyrosine Phosphatases

  2006cited by this paper
• A CD36‐dependent signaling cascade is necessary for macrophage foam cell formation

  2006cited by this paper
• Receptor‐stimulated oxidation of SHP‐2 promotes T‐cell adhesion through SLP‐76–ADAP

  2005cited by this paper
• A specific role of integrin Mac-1 in accelerated macrophage efflux to the lymphatics.

  2005cited by this paper
• EP 80317, a ligand of the CD36 scavenger receptor, protects apolipoprotein E‐deficient mice from developing atherosclerotic lesions

  2005cited by this paper
• Dyslipidemia associated with atherosclerotic disease systemically alters dendritic cell mobilization.

  2004cited by this paper
• Thrombospondin Induces RhoA Inactivation through FAK-dependent Signaling to Stimulate Focal Adhesion Disassembly*

  2004cited by this paper
• Low-Density Lipoprotein From Apolipoprotein E–Deficient Mice Induces Macrophage Lipid Accumulation in a CD36 and Scavenger Receptor Class A–Dependent Manner

  2004cited by this paper
• Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques.

  2004cited by this paper
• Stem Cell Transplantation Reveals That Absence of Macrophage CD36 Is Protective Against Atherosclerosis

  2004cited by this paper
• Reversible oxidation and inactivation of the tumor suppressor PTEN in cells stimulated with peptide growth factors.

  2004cited by this paper
• Matrix metalloproteinases and atherosclerosis

  2004cited by this paper
• A Cell Surface Receptor Complex for Fibrillar β-Amyloid Mediates Microglial Activation

  2003cited by this paper
• CD36: a critical anti-angiogenic receptor.

  2003cited by this paper
• Lipoprotein Lipase in the Arterial Wall: Linking LDL to the Arterial Extracellular Matrix and Much More

  2002cited by this paper
• Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo.

  2002cited by this paper
• A Novel Family of Atherogenic Oxidized Phospholipids Promotes Macrophage Foam Cell Formation via the Scavenger Receptor CD36 and Is Enriched in Atherosclerotic Lesions*

  2002cited by this paper
• Inflammation in atherosclerosis

  2002cited by this paper
• A CD36-initiated Signaling Cascade Mediates Inflammatory Effects of β-Amyloid*

  2002cited by this paper
• Scavenger Receptors Class A-I/II and CD36 Are the Principal Receptors Responsible for the Uptake of Modified Low Density Lipoprotein Leading to Lipid Loading in Macrophages*

  2002cited by this paper
• A CD36-initiated signaling cascade mediates inflammatory effects of beta-amyloid.

  2002cited by this paper
• The lamellipodium: where motility begins.

  2002cited by this paper
• CD36 associates with CD9 and integrins on human blood platelets.

  2001cited by this paper
• Is the class A macrophage scavenger receptor (SR-A) multifunctional? - The mouse's tale.

  2001cited by this paper
• Two Vicinal Cysteines Confer a Peculiar Redox Regulation to Low Molecular Weight Protein Tyrosine Phosphatase in Response to Platelet-derived Growth Factor Receptor Stimulation*

  2001cited by this paper
• Dramatic remodeling of advanced atherosclerotic plaques of the apolipoprotein E-deficient mouse in a novel transplantation model.

  2001cited by this paper
• Site-specific incorporation of a phosphotyrosine mimetic reveals a role for tyrosine phosphorylation of SHP-2 in cell signaling.

  2001cited by this paper
• CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism.

  2001cited by this paper
• Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1

  2000cited by this paper
• Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species.

  2000cited by this paper
• Atherosclerosis : Vascular biology

  2000cited by this paper
• CD36 and atherosclerosis

  2000cited by this paper
• Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice.

  2000cited by this paper
• A Null Mutation in Murine CD36 Reveals an Important Role in Fatty Acid and Lipoprotein Metabolism*

  1999cited by this paper
• Concerted Activity of Tyrosine Phosphatase SHP-2 and Focal Adhesion Kinase in Regulation of Cell Motility

  1999cited by this paper
• Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro.

  1999cited by this paper
• Reversible Inactivation of Protein-tyrosine Phosphatase 1B in A431 Cells Stimulated with Epidermal Growth Factor*

  1998cited by this paper
• Protein-tyrosine Phosphatase Shp-2 Regulates Cell Spreading, Migration, and Focal Adhesion*

  1998cited by this paper
• Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study.

  1997cited by this paper
• Tissue Factor in the Pathogenesis of Atherosclerosis

  1997cited by this paper
• CD36 Mediates the In Vitro Inhibitory Effects of Thrombospondin-1 on Endothelial Cells

  1997cited by this paper
• Reduced uptake of oxidized low density lipoproteins in monocyte-derived macrophages from CD36-deficient subjects.

  1995cited by this paper
• Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinases

  1995cited by this paper
• The machinery of cell crawling.

  1994cited by this paper
• Hepatocyte growth factor/scatter factor induces tyrosine phosphorylation of focal adhesion kinase (p125FAK) and promotes migration and invasion by oral squamous cell carcinoma cells.

  1994cited by this paper
• CD36 is a receptor for oxidized low density lipoprotein.

  1993cited by this paper
• Vitamin E consumption and the risk of coronary heart disease in men.

  1993cited by this paper
• Membrane glycoprotein IV (CD36) is physically associated with the Fyn, Lyn, and Yes protein-tyrosine kinases in human platelets.

  1991cited by this paper
• The antioxidant butylated hydroxytoluene protects against atherosclerosis.

  1991cited by this paper
• Experimental models of atherosclerosis regression.

  1983cited by this paper
• Sequential morphologic studies of regression of advanced atherosclerosis.

  1981cited by this paper
• STUDIES OF REGRESSION OF ADVANCED ATHEROSCLEROSIS IN EXPERIMENTAL ANIMALS AND MAN *

  1976cited by this paper
• Practical methods for plasma lipoprotein analysis.

  1968cited by this paper

• Increased mROS Generation Associates With Cardiovascular Risk in BioHEART‐CT PBMCs

  2026cites this paper
• Hypoxia-inducible factors link inflammation and lipid metabolism in atherosclerotic macrophages.

  2026cites this paper
• Scavenger receptors: key players in the immunological puzzle of lupus

  2025cites this paper
• Decoding the CD36-Centric Axis in Gastric Cancer: Insights into Lipid Metabolism, Obesity, and Hypercholesterolemia

  2025cites this paper
• Endothelial CD36 mediates diet-induced increases in aortic stiffness.

  2025cites this paper
• CD36 as a Therapeutic Target in Tumor Microenvironment and Lipid Metabolism.

  2025cites this paper
• 'Emerging cell-specific therapies in cardiovascular disease'.

  2025cites this paper
• Monocytes/Macrophages and Atherogenesis

  2025cites this paper
• Phenotypic Shifts in Macrophages Within Advanced Atherosclerotic Plaques in Humans

  2025cites this paper
• Pyruvate Carboxylase in Macrophages Aggravates Atherosclerosis by Regulating Metabolism Reprogramming to Promote Inflammatory Responses Through the Hypoxia‐Inducible Factor‐1 Signaling Pathway

  2025cites this paper
• Mitochondrial ROS drive foam cell formation via STAT5 signaling in atherosclerosis

  2025cites this paper
• Obstructive sleep apnea-associated hypertensive disorders in pregnancy: a literature review and clinical management strategies

  2025cites this paper
• The GLI3 may be involved in the damage process of Eimeria tenella to chicken cecal tissue.

  2025cites this paper
• YAP-mediated macrophage polarization is involved in progression of atherosclerosis.

  2025cites this paper
• Oxidized LDL stimulates PKM2-mediated mtROS production and phagocytosis

  2025cites this paper
• Jian-pi Qu-tan Hua-yu Decoction improves oxidative stress-induced inflammation in endothelial cells in atherosclerotic ApoE-/- mice through the NOX1-ROS-ERK1/2 pathway.

  2025cites this paper
• Redefining Macrophage Heterogeneity in Atherosclerosis: A Focus on Possible Therapeutic Implications

  2025cites this paper
• Tropomodulin1 regulates the biomechanical changes in macrophages induced by matrix stiffness

  2025cites this paper
• A Longitudinal Cohort Assessing the Carotid Intima-Media Thickness Progression and Cardiovascular Risk Factors in a Rural Black South African Community

  2025cites this paper
• Chlorogenic Acid Alleviates Ferroptosis Collectively Induced by Lipopolysaccharide and Interleukin‑6 in Bovine Mammary Epithelial Cells

  2025cites this paper
• Macrophage PIM1 Drives Atherosclerosis by Enhancing Foam Cell Formation Via CD36

  2025cites this paper
• Srsf3-Dependent APA Drives Macrophage Maturation and Limits Atherosclerosis

  2025cites this paper
• Protective effect of Allium hookeri water extract and its main compound, Cycloalliin, on foam cell formation in THP-1-derived macrophages

  2025cites this paper
• Inverse Agonists of Peroxisome Proliferator-Activated Receptor Gamma: Advances and Prospects in Cancer Treatment.

  2025cites this paper
• Porcine milk small extracellular vesicles modulate peripheral blood mononuclear cell proteome in vitro

  2025cites this paper
• The Role of CD36 and Its Regulatory Mechanisms in Metabolic Dysregulation and Tumorigenesis

  2025cites this paper
• Dysregulated cellular metabolism in atherosclerosis: mediators and therapeutic opportunities

  2024cites this paper
• Myeloid-T cell interplay and cell state transitions associated with checkpoint inhibitor response in melanoma.

  2024cites this paper
• PCSK9 Inhibitors: Focus on Evolocumab and Its Impact on Atherosclerosis Progression

  2024cites this paper
• CXCL16-dependent scavenging of oxidized lipids by islet macrophages promotes differentiation of pathogenic CD8+ T cells in diabetic autoimmunity.

  2024cites this paper
• The regulatory role of CD36 in hematopoiesis beyond fatty acid uptake.

  2024cites this paper
• Effect of LDL Extracted from Human Plasma on Membrane Stiffness in Living Endothelial Cells and Macrophages via Scanning Ion Conductance Microscopy

  2024cites this paper
• The influence of metabolic disorders on adaptive immunity

  2024cites this paper
• One immune cell to bind them all: platelet contribution to neurodegenerative disease

  2024cites this paper
• MUC1 promotes RIF by regulating macrophage ROS-SHP2 signaling pathway to up-regulate inflammatory response and inhibit angiogenesis

  2024cites this paper
• Mechanisms and consequences of myeloid adhesome dysfunction in atherogenesis.

  2024cites this paper
• Macrophage polarisation and inflammatory mechanisms in atherosclerosis: Implications for prevention and treatment

  2024cites this paper
• Targeting Unc5b in macrophages drives atherosclerosis regression and pro-resolving immune cell function

  2024cites this paper
• Targeting Cysteine Oxidation in Thrombotic Disorders

  2024cites this paper
• Capsaicin Improves Systemic Inflammation, Atherosclerosis, and Macrophage-Derived Foam Cells by Stimulating PPAR Gamma and TRPV1 Receptors

  2024cites this paper
• Plexin D1 negatively regulates macrophage-derived foam cell migration via the focal adhesion kinase/Paxillin pathway.

  2024cites this paper
• Melanoma-Derived Extracellular Vesicles Induce CD36-Mediated Pre-Metastatic Niche

  2024cites this paper
• CD36 as a gatekeeper of myocardial lipid metabolism and therapeutic target for metabolic disease.

  2023cites this paper
• Innate Immune Pathways in Atherosclerosis—From Signaling to Long-Term Epigenetic Reprogramming

  2023cites this paper
• Short-chain fatty acids are potential goalkeepers of atherosclerosis

  2023cites this paper
• Stearic acid promotes lipid synthesis through CD36/Fyn/FAK/mTORC1 axis in bovine mammary epithelial cells.

  2023cites this paper
• Macrophage polarization and metabolism in atherosclerosis

  2023cites this paper
• Multi-proteomic Biomarker Risk Scores for Predicting Risk and Guiding Therapy in Patients with Coronary Artery Disease

  2023cites this paper
• Is the suppression of CD36 a promising way for atherosclerosis therapy?

  2023cites this paper
• The Changing Face of Atherosclerosis

  2023cites this paper
• Endothelial exosomes work as a functional mediator to activate macrophages

  2023cites this paper
• The Role of CD36 in Cancer Progression and Its Value as a Therapeutic Target

  2023cites this paper
• Molecular Markers of Early Immune Response in Tuberculosis: Prospects of Application in Predictive Medicine

  2023cites this paper
• Unbalanced Redox With Autophagy in Cardiovascular Disease

  2023cites this paper
• Monocyte and macrophage foam cells in diabetes-accelerated atherosclerosis

  2023cites this paper
• The role of fibrinolysis in the development of prediabetes-associated coronary heart disease: a focus on the plasminogen activator inhibitor -1 and its potential use as a predictive marker in diet-induced prediabetes

  2023cites this paper
• Two decades of vaccine development against atherosclerosis.

  2023cites this paper
• Phosphatidylethanolamine alleviates OX-LDL-induced macrophage inflammation by upregulating autophagy and inhibiting NLRP1 inflammasome activation.

  2023cites this paper
• Contribution of adipocyte Na/K-ATPase α1/CD36 signaling induced exosome secretion in response to oxidized LDL

  2023cites this paper
• Inflammasome activation mediated by oxidised low-density lipoprotein in patients with sleep apnoea and early subclinical atherosclerosis

  2022cites this paper
• Advanced glycation endproducts in diabetes-related macrovascular complications: focus on methylglyoxal.

  2022cites this paper
• A CD36 transmembrane domain peptide interrupts CD36 interactions with membrane partners on macrophages and inhibits atherogenic functions.

  2022cites this paper
• Senescence-Associated Secretory Phenotype of Cardiovascular System Cells and Inflammaging: Perspectives of Peptide Regulation

  2022cites this paper
• Oxidative modification of HDL by lipid aldehydes impacts HDL function.

  2022cites this paper
• Role of advanced glycation end products on vascular smooth muscle cells under diabetic atherosclerosis

  2022cites this paper
• Novel role for caspase 1 inhibitor VX765 in suppressing NLRP3 inflammasome assembly and atherosclerosis via promoting mitophagy and efferocytosis

  2022cites this paper
• Intramyocardial hemorrhage drives fatty degeneration of infarcted myocardium

  2022cites this paper
• Novel role for caspase 1 inhibitor VX765 in suppressing NLRP3 inflammasome assembly and atherosclerosis via promoting mitophagy and efferocytosis

  2022cites this paper
• Advanced Glycation End Products: key player of the pathogenesis of atherosclerosis

  2022cites this paper
• Follicle-Stimulating Hormone Provokes Macrophages to Secrete IL-1β Contributing to Atherosclerosis Progression.

  2022cites this paper
• The central moTOR of metabolism.

  2022cites this paper
• High fructose diet: A risk factor for immune system dysregulation.

  2022cites this paper
• Etiopathogenesis of insulin resistance

  2022cites this paper
• CD36 regulates LPS-induced acute lung injury by promoting macrophages M1 polarization.

  2022cites this paper
• CD36, a signaling receptor and fatty acid transporter that regulates immune cell metabolism and fate

  2022cites this paper
• Atherosclerosis: The Involvement of Immunity, Cytokines and Cells in Pathogenesis, and Potential Novel Therapeutics

  2022cites this paper
• OxLDL induces membrane structure rearrangement leading to biomechanics alteration and migration deficiency in macrophage.

  2022cites this paper
• TRPM2 deficiency in mice protects against atherosclerosis by inhibiting TRPM2-CD36 inflammatory axis in macrophages

  2022cites this paper
• Structure of Lipoproteins and Their Capacity for Lipid Exchange: Relevance for Development of Atherosclerosis and Its Treatment by HDL Therapy

  2021cites this paper
• Assessment of ENDPs in Animal Models of Disease

  2021cites this paper
• Macrophage Proteome Analysis at Different Stages of Mycobacterium avium Subspecies paratuberculosis Infection Reveals a Mechanism of Pathogen Dissemination

  2021cites this paper
• Antibody-Based Therapeutics for Atherosclerosis and Cardiovascular Diseases

  2021cites this paper
• The neurorepellent, Slit2, prevents macrophage lipid loading by inhibiting CD36-dependent binding and internalization of oxidized low-density lipoprotein

  2021cites this paper
• Endothelial Cell CD36 Reduces Atherosclerosis and Controls Systemic Metabolism

  2021cites this paper
• Metabolism of tissue macrophages in homeostasis and pathology

  2021cites this paper
• Regulation of Macrophage Activation and Differentiation in Atherosclerosis

  2021cites this paper
• Lipid Scavenging Macrophages and Inflammation.

  2021cites this paper
• TRPM2 deficiency protects against atherosclerosis by inhibiting TRPM2-CD36 inflammatory axis in macrophages

  2021cites this paper
• CCL7 contributes to angiotensin II‐induced abdominal aortic aneurysm by promoting macrophage infiltration and pro‐inflammatory phenotype

  2021cites this paper
• Myeloid-associated lipin-1 transcriptional co-regulatory activity is atheroprotective.

  2021cites this paper
• The roles of immune cells in atherosclerotic calcification

  2021cites this paper
• Fatty acids and evolving roles of their proteins in neurological, cardiovascular disorders and cancers.

  2021cites this paper
• The Entry and Egress of Monocytes in Atherosclerosis: A Biochemical and Biomechanical Driven Process

  2021cites this paper
• Novel insights: Dynamic foam cells derived from the macrophage in atherosclerosis

  2021cites this paper
• Biological drug and drug delivery-mediated immunotherapy

  2020cites this paper
• miRNA‐mediated macrophage behaviors responding to matrix stiffness and ox‐LDL

  2020cites this paper
• Differential expression of glycoprotein IV on monocyte subsets following high-fat diet feeding and the impact of short-term low-dose aspirin treatment

  2020cites this paper
• Mitochondria orchestrate macrophage effector functions in atherosclerosis.

  2020cites this paper
• Anti-Inflammatory Actions of Soluble Ninjurin-1 Ameliorate Atherosclerosis

  2020cites this paper
• The role of CD36 in cardiovascular disease

  2020cites this paper